DINO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HF Sinclair Corp (DINO) is not a good buy for a beginner, long-term investor at this moment. The company's financial performance has been weak, with significant declines in net income and EPS. Additionally, the ongoing management turmoil, including the CEO and CFO's voluntary leaves of absence amid a securities fraud investigation, raises concerns about transparency and leadership stability. While the technical indicators show some positive momentum, the lack of strong proprietary trading signals and the negative sentiment from hedge funds and analysts suggest caution. The user should wait for more clarity on the company's internal issues and improved financial performance before considering an investment.
The MACD histogram is positive and expanding (0.275), suggesting bullish momentum. However, the RSI is at 75.603, which is neutral, and moving averages are converging, indicating no clear trend. The stock is trading near its resistance level (R1: 57.304), which may limit further upside in the short term.
The company's gross margin increased significantly (up 97.06% YoY), indicating operational efficiency. Additionally, the company's Fueling Folds of Honor campaign raised over $1 million, which may improve public perception.
The CEO and CFO's voluntary leaves of absence amid a securities fraud investigation have caused significant uncertainty. Analysts have downgraded the stock and lowered price targets, citing concerns about transparency and management turmoil. Hedge funds are also selling, with a 265.50% increase in selling activity over the last quarter.
In 2025/Q3, revenue increased slightly by 0.61% YoY to $7.25 billion. However, net income dropped significantly by -623.08% YoY to $400 million, and EPS fell by -635.00% YoY to 2.14. While gross margin improved to 17.42 (up 97.06% YoY), the overall financial performance is weak.
Analysts have mixed views. BMO Capital and Morgan Stanley maintain an Outperform/Overweight rating but have lowered price targets to $60 and $57, respectively. Piper Sandler and Scotiabank downgraded the stock, citing management uncertainty and weak Q4 results. The consensus is cautious, with significant concerns about the company's leadership and transparency.
